RLY-8161
RLY-8161-101
Phase 1 small_molecule active
Quick answer
RLY-8161 for NRAS Mutation is a Phase 1 program (small_molecule) at Relay Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Relay Therapeutics
- Indication
- NRAS Mutation
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active